LIR Life Sciences Corp.

C$0.14As of Sun 8 Nov 2026, 12:00 UTC
CSE:SKNYHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Pharmaceutical Preparations
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap C$4.013M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.154
10.30%
(11.66%)
Hold 12|4|10|1|7
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
7.17%
12.39%
24.28%
26.49%
Revenue$M
0.221
0.224
0.232
0.228
(0.11%)
(2.58%)
3.17%
1.23%
Peers (US$2.841M)
Cap (US$)
PE
3.016M
11.78x
Capital
TTM
5Y
10Y
Leveragex
0.412
(0.010)
(0.012)
EBIT/Intx
3.977
0.528
0.527
Own earn%
20.98
(51.56)
(49.13)
Sh yield%
14.83
20.32
20.20
Owners
Insiders/Inst%
9.84
53.82
Short interest%
2.85
SBC / revenue%
0.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
18–25
$1 testx
0.0
Incr. ROIC%
−3